How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?
- 28 June 2005
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (7) , 1979-1985
- https://doi.org/10.1002/art.21133
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trialArthritis & Rheumatism, 2005
- Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow upAnnals of the Rheumatic Diseases, 2004
- Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 yearsAnnals of the Rheumatic Diseases, 2004
- Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologistsAnnals of the Rheumatic Diseases, 2004
- Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working ageAnnals of the Rheumatic Diseases, 2003
- Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trialArthritis & Rheumatism, 2003
- Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trialThe Lancet, 2002
- Combined spa–exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trialArthritis & Rheumatism, 2001
- QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITISRheumatic Disease Clinics of North America, 1998
- Is group physical therapy superior to individualized therapy in ankylosing spondylitis? A randomized controlled trialArthritis & Rheumatism, 1993